JY
NRXP icon

Jeff Yass’s NRX Pharmaceuticals NRXP Stock Holding History

Jeff Yass’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$928K Buy
226,800
+157,100
+225% +$519K ﹤0.01% 8385
2026
Q1 		$148K Buy
69,700
+41,900
+151% +$84.6K ﹤0.01% 12012
2025
Q4 		$75.3K Sell
27,800
-13,800
-33% -$37K ﹤0.01% 11592
2025
Q3 		$137K Buy
+41,600
New +$119K ﹤0.01% 11348
2025
Q2 		– Sell
-54,700
Closed -$112K – 13391
2025
Q1 		$112K Buy
+54,700
New +$154K ﹤0.01% 11466
2024
Q4 		– Sell
-20,500
Closed -$34.6K – 12886
2024
Q3 		$34.6K Sell
20,500
-40,000
-66% -$80.6K ﹤0.01% 11499
2024
Q2 		$148K Buy
60,500
+57,130
+1,695% +$203K ﹤0.01% 10709
2024
Q1 		$15.8K Buy
3,370
+1,580
+88% +$7.28K ﹤0.01% 11858
2023
Q4 		$8.23K Hold
1,790
– – ﹤0.01% 12087
2023
Q3 		$4.65K Sell
1,790
-20
-1% -$67 ﹤0.01% 11798
2023
Q2 		$8.69K Sell
1,810
-10
-0.5% -$60 ﹤0.01% 11774
2023
Q1 		$12K Sell
1,820
-1,300
-42% -$13.2K ﹤0.01% 12172
2022
Q4 		$34.6K Sell
3,120
-3,500
-53% -$35.3K ﹤0.01% 11575
2022
Q3 		$49K Buy
6,620
+290
+5% +$1.96K ﹤0.01% 12218
2022
Q2 		$38K Sell
6,330
-6,550
-51% -$86K ﹤0.01% 12117
2022
Q1 		$316K Buy
12,880
+2,160
+20% +$70.3K ﹤0.01% 10145
2021
Q4 		$512K Sell
10,720
-3,170
-23% -$229K ﹤0.01% 9137
2021
Q3 		$1.29M Buy
+13,890
New +$1.81M ﹤0.01% 6900

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's NRXP Position: Q1 2025 in Review

Jeff Yass sold out of NRX Pharmaceuticals (NRXP) in Q1 2025, closing a stake of 82,152 shares — an estimated $231K sold.

Jeff Yass first reported a position in NRXP in Q2 2019 and held it in 10 quarters. The position peaked at $513K in Q3 2021. 22 funds tracked by Wall St. Rank hold NRXP as of Q1 2025.

  • Jeff Yass reported no remaining NRX Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Jeff Yass sold 82,152 NRX Pharmaceuticals shares in Q1 2025, an estimated $231K.
  • Jeff Yass first reported a position in NRX Pharmaceuticals in Q2 2019 and held it in 10 quarters.
  • Jeff Yass's NRX Pharmaceuticals position peaked at $513K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.